BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6479538)

  • 1. Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites.
    Schölmerich J; Volk BA; Köttgen E; Ehlers S; Gerok W
    Gastroenterology; 1984 Nov; 87(5):1160-4. PubMed ID: 6479538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
    Rieder H; Ramadori G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibronectin in the ascitic fluid: its diagnostic significance].
    Mal F; Nizard G; Labadie H; Trinchet JC; Garnier M; Beaugrand M
    Gastroenterol Clin Biol; 1987 Oct; 11(10):639-42. PubMed ID: 2826281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fibronectin in diagnosis of malignant ascites.
    Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
    J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-ascites albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites.
    Paré P; Talbot J; Hoefs JC
    Gastroenterology; 1983 Aug; 85(2):240-4. PubMed ID: 6862152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of fibronectin concentration in benign and malignant ascites.
    Adamsen S; Jönsson P; Brodin B; Lindberg B; Jorpes P
    Eur J Surg; 1991 May; 157(5):325-8. PubMed ID: 1678645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biochemical markers of the tumor origin of ascites].
    Romette J; di Costanzo-Dufetel J
    Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].
    Barbare JC; Diab G; Delavenne J; Philippe JM; Vorhauer W; Latrive JP; Capron JP
    Ann Gastroenterol Hepatol (Paris); 1989 Nov; 25(6):251-6. PubMed ID: 2619252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
    Khan FY
    Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of ascitic fibronectin and cholesterol concentration in the differentiation between malignancy-related and non-malignant ascites.
    Archimandritis A; Kapsalas D; Douvara M; Tjivras M; Tsirantonaki M; Fertakis A
    Ann Med Interne (Paris); 1996; 147(3):145-50. PubMed ID: 8796090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
    Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
    Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
    Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
    Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of fibronectin as a marker of malignant ascites.
    Siddiqui RA; Kochhar R; Singh V; Rajwanshi A; Goenka MK; Mehta SK
    J Gastroenterol Hepatol; 1992; 7(2):161-4. PubMed ID: 1571498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosing ascitic etiology on a biochemical basis.
    Bansal S; Kaur K; Bansal AK
    Hepatogastroenterology; 1998; 45(23):1673-7. PubMed ID: 9840127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent aspects in the diagnosis and therapy of ascites].
    Gerbes AL
    Z Gastroenterol; 1987 Oct; 25(10):677-82. PubMed ID: 3318185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods.
    Bala L; Sharma A; Yellapa RK; Roy R; Choudhuri G; Khetrapal CL
    NMR Biomed; 2008 Jul; 21(6):606-14. PubMed ID: 18205245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of ascitic lipids and sero-ascitic gradient of albumin in the differential diagnosis of ascites].
    Cabral JE; Leitão MC; Guerra C; Tomé L; Pinto ML; Costa D; Monteiro G
    Acta Med Port; 1989; 2(1):17-20. PubMed ID: 2773676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascitic fluid cholesterol in malignant and tubercular ascites.
    Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
    J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
    Rana SV; Babu SG; Kocchar R
    Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic paracentesis. A two-step approach.
    Sartori M; Andorno S; Gambaro M; Leone F; Molinari GL; Pontiroli L; Aglietta M
    Ital J Gastroenterol; 1996; 28(2):81-5. PubMed ID: 8781999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.